Sitewide
Tumors use enzyme to recruit regulatory T-cells and suppress immune response
One way tumors fly under the radar of the immune system is by using IDO, an enzyme used by fetuses to help avoid rejection, to recruit powerful regulatory T cells that turn down the immune response, researchers say.
Similar Articles On This Topic:
- Cancer stem cells suppress immune response against brain tumor
- Gene therapy eliminates brain tumors through selective recruitment of immune cells
- Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers
- Moffitt Cancer Center researchers find regulatory T-cell clue to help prevent GVHD
- Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
Popular Today:
Science 2.0:
- Science Can Save Crops, Forests And Endangered Animals By Doing This One Thing
- Organic Carbon In Meteorites Came From Mars
- Is That A Dragon In Your Berth Or Are You Just Happy To See Me?
- Are Anthropogenic Pressures Increasing The Speed Of Bacterial Evolution?
- From Towel Day To SpaceX And Transparency Grenades
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment